Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance

The U.S. Food and Drug Administration has cleared Roche and partner Eli Lilly's blood test to help ​identify signs of Alzheimer's disease in people aged ‌55 and older with cognitive decline.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。